| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/24/2009 | US20090239848 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE |
| 09/24/2009 | US20090239841 Diaryl Ureas as CB1 Antagonists |
| 09/24/2009 | US20090239839 Receptor antagonist |
| 09/24/2009 | US20090239823 Foods and drinks having health benefits and method for adding health benefits to foods and drinks |
| 09/24/2009 | US20090239810 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE |
| 09/24/2009 | US20090239809 Process For Preparing Peptide Products For Promoting Cholecystokinin Secretion And Use Of The Peptide Products |
| 09/24/2009 | US20090239801 Modified Fusion Polypeptides |
| 09/24/2009 | US20090239796 Methods for treating diabetes and reducing body weight |
| 09/24/2009 | US20090239785 Insulin Derivative |
| 09/24/2009 | US20090239784 Stablised Insulin Compositions |
| 09/24/2009 | US20090239301 Use of vinca alkaloids and salts thereof |
| 09/24/2009 | US20090238900 Novel anti-diabetic herbal composition, method for preparing the same and use thereof |
| 09/24/2009 | US20090238886 Retro-Inversion Peptides That Target GIT Transport Receptors and Related Methods |
| 09/24/2009 | US20090238879 Delivery scaffolds and related methods of use |
| 09/24/2009 | US20090238870 Dividable galenical form allowing modified release of the active ingredient |
| 09/24/2009 | US20090238866 Chewable capsules |
| 09/24/2009 | US20090238838 Insulinotropic peptide conjugate using an immunoglobulin fc |
| 09/24/2009 | US20090238803 Human cord blood derived unrestricted somatic stem cells (ussc) |
| 09/24/2009 | US20090238802 Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem Cells |
| 09/24/2009 | CA2719134A1 Treatment with opioid antagonists and mtor inhibitors |
| 09/24/2009 | CA2716676A1 Inhibitor for blood phosphorus level elevation |
| 09/23/2009 | EP2103613A1 Quinoxaline derivative |
| 09/23/2009 | EP2103607A1 1-phenyl 1-thio-d-glucitol derivative |
| 09/23/2009 | EP2103603A1 Method for producing pyrrolidine compound |
| 09/23/2009 | EP2103598A1 Fluorinated cycloalkyl-derived benzoylguanidine, method for producing same, use of same as medicine and medicine containing same |
| 09/23/2009 | EP2102340A2 Methods for treating hypercholesterolemia |
| 09/23/2009 | EP2102215A1 4,5,6,7-tetrahydro-thieno [2,3-c]pyridines as h3 modulators |
| 09/23/2009 | EP2102214A1 4, 5, 6, 7-tetrahydro-thieno [3, 2-c] pyridine derivatives as h3 modulators |
| 09/23/2009 | EP2102208A1 Novel substituted diaza spiro pyridinone derivatives for use in mch-1 mediated diseases |
| 09/23/2009 | EP2102198A1 Sulfonyl-phenyl-2h-[1,2,4]oxodiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals |
| 09/23/2009 | EP2102197A1 5-([1,3,4]oxadiazol-2-yl)-1h-indazol and 5-([1,3,4]thiadiazol-2-yl)-1h-indazol derivatives as sgk inhibitors for the treatment of diabetes |
| 09/23/2009 | EP2102188A2 Compounds |
| 09/23/2009 | EP2102171A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds |
| 09/23/2009 | EP2102155A1 Aryl compounds as ppar ligands and their use |
| 09/23/2009 | EP2101822A2 Use of peptides in combination with surgical intervention for the treatment of obesity |
| 09/23/2009 | EP2101810A2 Chymosin for the prevention and treatment of gastrointestinal disorders |
| 09/23/2009 | EP2101800A1 Extracts from the skin of fruits of plants from genus vitis, compositions containing the same and a process for its manufacture |
| 09/23/2009 | EP2101757A1 Compound for treatment or prevention of prostate-related diseases and pharmaceutical composition of colon delivery system containing the same |
| 09/23/2009 | EP2101753A2 Use of cytohesin inhibitors for chemically inducing longevity |
| 09/23/2009 | EP2101749A1 Pharmaceutical composition comprising shikonin derivatives from lithospermum erythrorhizon for treating or preventing diabetes mellitus and the use thereof |
| 09/23/2009 | EP1651213B1 Use of angiotensin ii receptor antagonists, especially telmisartan, in order to increase insulin sensitivity |
| 09/23/2009 | EP1583547B1 Anti-obesity ingredients from medicinal plants and their composition |
| 09/23/2009 | EP1416966B1 Methods for treating joint inflammation, pain, and loss of mobility |
| 09/23/2009 | EP1377288B1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and use |
| 09/23/2009 | EP1283682B1 Tryptophan source from plants and uses therefor |
| 09/23/2009 | CN101538569A RNA and recombinant for inhibiting human DMT1 protein and application thereof |
| 09/23/2009 | CN101538568A RNA and recombinant for inhibiting human ferroportin and application thereof |
| 09/23/2009 | CN101538557A Recombinant human divalent metal ion transporter adenovirusm and preparation method and application thereof |
| 09/23/2009 | CN101538324A Method for preparing Exenatide |
| 09/23/2009 | CN101538323A Method for purifying exenatide |
| 09/23/2009 | CN101538293A Method for preparing secoisolariciresinol diglucoside and ferulic acid glucoside or ferulic acid glucoside ethyl ester |
| 09/23/2009 | CN101538278A High-purity egg yolk lecithin and production method and applications thereof |
| 09/23/2009 | CN101538244A 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 09/23/2009 | CN101538238A Polymorphs of atorvastatin tert.-butylester and use as intermediates for the preparation of atorvastatin |
| 09/23/2009 | CN101538237A Atorvastatin semi-calcium salt butanone co-crystallization substances, preparation and application thereof as HMG-CoA enzyme inhibitor |
| 09/23/2009 | CN101538230A Beta-amino ketones compound with anti-diabetic activity |
| 09/23/2009 | CN101538218A Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
| 09/23/2009 | CN101537182A Combination comprising an HMG CoA reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer |
| 09/23/2009 | CN101537181A Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and / or congestive heart failure |
| 09/23/2009 | CN101537178A Method for filing nitrogen in partial vacuum after freezing out rabies vaccine |
| 09/23/2009 | CN101537174A Health preserving calcium |
| 09/23/2009 | CN101537162A Chinese traditional medicine for curing Type II diabetes mellitus |
| 09/23/2009 | CN101537160A Health product for toxicant elimination and beauty maintenance |
| 09/23/2009 | CN101537119A Chinese traditional medicine preparation for curing diabetes mellitus |
| 09/23/2009 | CN101537117A Drug for curing diabetes and preparation method thereof |
| 09/23/2009 | CN101537102A Medical and edible dual-purpose composition for treating sugar diabetes and preparation method thereof |
| 09/23/2009 | CN101537097A Jiangtang capsule for curing diabetes mellitus |
| 09/23/2009 | CN101537086A Pharmaceutical composition for resisting hepatitis B virus, lowering lipid and alleviating fatty live lesions and preparation method thereof |
| 09/23/2009 | CN101537072A Chinese herbal medicine preparation for curing diabetes mellitus |
| 09/23/2009 | CN101537054A Preparation capable of clearing blood and softening pulse, tonifying heart and protecting brain and adjusting blood fat and blood pressure, and preparation method thereof |
| 09/23/2009 | CN101537052A Hubei caval vine general flavone extract as well as preparation method and application thereof |
| 09/23/2009 | CN101537050A Health product capable of enhancing bone density and immune function, and preparation method and applications thereof |
| 09/23/2009 | CN101537048A Application of buckwheat and bee pollen in preparing drugs and method for preparing capsules and tablets thereby |
| 09/23/2009 | CN101537046A Blood lipid-lowing active fractions of forsythia suspensa and preparation method and use of same |
| 09/23/2009 | CN101537035A Qi benefiting and viscosity breaking particle and preparation method thereof |
| 09/23/2009 | CN101537012A Complex vitamin freeze-dried powder injection and preparation method thereof |
| 09/23/2009 | CN101536993A Vitamin D3 microcapsule and preparation method thereof |
| 09/23/2009 | CN101536989A Metformin hydrochloride intragastric floating sustained-release tablet and preparation method thereof |
| 09/23/2009 | CN101536970A Shower gel with weight reducing function |
| 09/23/2009 | CN100543022C 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same |
| 09/23/2009 | CN100543016C Intermediate compound of 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives |
| 09/23/2009 | CN100542609C Compositions comprising dietary fat complex and methods for their use |
| 09/23/2009 | CN100542541C Safety compound biologic calcium formulation |
| 09/23/2009 | CN100542525C Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate |
| 09/22/2009 | US7592477 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (PTPs) |
| 09/22/2009 | US7592455 potent and selective inhibitors of p38 kinase, especially p38 alpha , p38 beta and p38 beta 2; immune or inflammatory disorders; Ethyl 3-(benzylamino)-6-oxo-7-phenyl-6,7-dihydrothieno[2,3-b]pyridine-2-carboxylate |
| 09/22/2009 | US7592454 Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists |
| 09/22/2009 | US7592451 Glyceraldehyde 3-phosphate dehydrogenase (GADPH) inhibitors and screening compounds |
| 09/22/2009 | US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability |
| 09/22/2009 | US7592373 Metabolism diosrders; eating disorders; obesity; antidiabetic agents; incontinence; melanin concentrating hormone; 3-[4-(4-methylpiperidin-1-ylmethyl)phenyl]propynoic acid-(4'-chloro-2'-fluorobiphenyl-4-yl)amide, for example |
| 09/22/2009 | US7592354 Administering a stimulantfor the endogenous production/ release of somatotropins; 3-((1-(2-aminoprop-2-yl)carbonylamino-),2-(phenylmethoxymethyl-)ethyl-),5-(morpholino-carbonyloxymethyl-)-5,6,7,8-tetrahydro-1,2,4-triazolo(4,3-)pyridine; osteoporosis; obesity;improving bone densisty, muscle mass/strength |
| 09/22/2009 | US7592350 Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 09/22/2009 | US7592305 Use of ghrelin for treating malnutrition in gastrectomized individuals |
| 09/22/2009 | US7592010 Extending the shelf life of Therapeutic protein X; nucleic acids and vectors containing them; kits; treating, preventing, or ameliorating diseases, disorders or conditions |
| 09/22/2009 | US7591949 Method for the improvement of transport across adaptable semi-permeable barriers |
| 09/22/2009 | CA2487450C (2s)-2-ethylphenylpropanoic acid derivatives |
| 09/22/2009 | CA2449917C Amino acid mixture-containing agent capable of raising body temperature for food or drink use and medical use |
| 09/22/2009 | CA2426349C Over-coated chewing gum formulations including tableted center |
| 09/22/2009 | CA2419588C Piperidine derivatives for use 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 09/22/2009 | CA2402121C Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |